model 4800 maldi tof tof analyzer Search Results


k-4800  (Echelon Biosciences)
93
Echelon Biosciences k-4800
K 4800, supplied by Echelon Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/model+4800+maldi+tof+tof+analyzer/k-4800/custom%40k-4800%4036359309
Average 93 stars, based on 1 article reviews
k-4800 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
abi 4800 proteomics tof/tof analyzer  (AB Science)
90
AB Science abi 4800 proteomics tof/tof analyzer
Abi 4800 Proteomics Tof/Tof Analyzer, supplied by AB Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/model+4800+maldi+tof+tof+analyzer/abi+4800+proteomics+tof+tof+analyzer/pmc04698204-85-13-17
Average 90 stars, based on 1 article reviews
abi 4800 proteomics tof/tof analyzer - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
maldi-tof tof 4800  (Micromass UK Limited)
90
Micromass UK Limited maldi-tof tof 4800
Maldi Tof Tof 4800, supplied by Micromass UK Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/model+4800+maldi+tof+tof+analyzer/maldi+tof+tof+4800/pmc06117704-187-12-15
Average 90 stars, based on 1 article reviews
maldi-tof tof 4800 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
ms ms  (Danaher Inc)
97
Danaher Inc ms ms
Ms Ms, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/model+4800+maldi+tof+tof+analyzer/Echo+MS+System/10__1074_slash_jbc__ra119__010796-166-12-13
Average 97 stars, based on 1 article reviews
ms ms - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier
4800 maldi-tof/tof mass spectrometer  (PerSeptive Biosystems Inc)
90
PerSeptive Biosystems Inc 4800 maldi-tof/tof mass spectrometer
4800 Maldi Tof/Tof Mass Spectrometer, supplied by PerSeptive Biosystems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/model+4800+maldi+tof+tof+analyzer/maldi+tof+tof+mass+spectrometer+4700+proteomics+analyzer/pmc09671362-89-6-10
Average 90 stars, based on 1 article reviews
4800 maldi-tof/tof mass spectrometer - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
4800 maldi tof/tof analyzer  (Shotgun Proteomics company)
90
Shotgun Proteomics company 4800 maldi tof/tof analyzer
Ovarian cancer cell secretome increases HOMEC cellular responses and contains a range of potential proangiogenic proteins. (A) Proliferation of HOMECs treated with CM from SKOV3 and A2780 cells for 24, 48, or 72 hours assessed using the WST-1 assay. Controls received basal medium only. **P ≤ .01 and ***P ≤ .001 versus control levels (100%). (B) Migration of HOMECs in co-culture with ovarian cancer cells and HDFs (co-culture control) assessed by the ThinCert migration assay. After 24 hours, fluorescence of migrated cells was quantified. ***P ≤ .001 versus control (100%) and ###P ≤ .001 versus HDFs. (C) HOMEC Oris cell migration after 48 hours in the presence of VEGFA165 (20 ng/ml) ± SU5416 (10 µM). Controls received medium alone. ***P ≤ .001 versus control (100%) and ###P ≤ .001 versus VEGFA165. (D) Migration of HOMECs in co-culture with ovarian cancer cells ± anti-VEGFA antibody (500 ng/ml) or SU5416 (10 µM) assessed by the ThinCert migration assay. ***P ≤ .001 versus control (100%), **P ≤ .01 versus control (100%), and NS versus A2780 or SKOV3. (E) VEGF- and EOC cell-induced tube-like structure formation of HOMECs and the effects of the SU5416 inhibitor. HOMECs were plated onto fibrin matrices and exposed to either VEGFA165 or EOC cells in co-culture ± SU5416 (10 µM). Negative controls received medium alone. Tube-like structure formation was quantified. *P ≤ .05, **P ≤ .01, and ***P ≤ .001 versus control (100%), ###P ≤ .001 versus VEGF, and NS versus SKOV3/A2780. For A to E, data are presented as means ± SD. P values were calculated by one-way analysis of variance (ANOVA), followed by Tukey's post hoc test. (F) Shotgun proteomics of SKOV3 CM by the <t>4800</t> <t>MALDI</t> TOF/TOF analyzer. Significant results were determined by selecting proteins that matched with two or more peptides with total ion CIs of >95%, followed by a literature search to determine proteins with a possible role in angiogenesis. (G) Analysis of CL, CD, IGFBP-7, and VEGF concentration in CM from SKOV3 and A2870. Commercially available ELISAs were used for determination of VEGF, CD, and CL concentrations, whereas the IGFBP-7 ELISA protocol was developed in-house. All experiments were carried out in duplicate on three separate samples. B/D, below detection limit.
4800 Maldi Tof/Tof Analyzer, supplied by Shotgun Proteomics company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/model+4800+maldi+tof+tof+analyzer/4800+maldi+tof+tof+analyzer/pmc03890705-196-24-17
Average 90 stars, based on 1 article reviews
4800 maldi tof/tof analyzer - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
mass spectrometers  (Thermo Fisher)
99
Thermo Fisher mass spectrometers
Ovarian cancer cell secretome increases HOMEC cellular responses and contains a range of potential proangiogenic proteins. (A) Proliferation of HOMECs treated with CM from SKOV3 and A2780 cells for 24, 48, or 72 hours assessed using the WST-1 assay. Controls received basal medium only. **P ≤ .01 and ***P ≤ .001 versus control levels (100%). (B) Migration of HOMECs in co-culture with ovarian cancer cells and HDFs (co-culture control) assessed by the ThinCert migration assay. After 24 hours, fluorescence of migrated cells was quantified. ***P ≤ .001 versus control (100%) and ###P ≤ .001 versus HDFs. (C) HOMEC Oris cell migration after 48 hours in the presence of VEGFA165 (20 ng/ml) ± SU5416 (10 µM). Controls received medium alone. ***P ≤ .001 versus control (100%) and ###P ≤ .001 versus VEGFA165. (D) Migration of HOMECs in co-culture with ovarian cancer cells ± anti-VEGFA antibody (500 ng/ml) or SU5416 (10 µM) assessed by the ThinCert migration assay. ***P ≤ .001 versus control (100%), **P ≤ .01 versus control (100%), and NS versus A2780 or SKOV3. (E) VEGF- and EOC cell-induced tube-like structure formation of HOMECs and the effects of the SU5416 inhibitor. HOMECs were plated onto fibrin matrices and exposed to either VEGFA165 or EOC cells in co-culture ± SU5416 (10 µM). Negative controls received medium alone. Tube-like structure formation was quantified. *P ≤ .05, **P ≤ .01, and ***P ≤ .001 versus control (100%), ###P ≤ .001 versus VEGF, and NS versus SKOV3/A2780. For A to E, data are presented as means ± SD. P values were calculated by one-way analysis of variance (ANOVA), followed by Tukey's post hoc test. (F) Shotgun proteomics of SKOV3 CM by the <t>4800</t> <t>MALDI</t> TOF/TOF analyzer. Significant results were determined by selecting proteins that matched with two or more peptides with total ion CIs of >95%, followed by a literature search to determine proteins with a possible role in angiogenesis. (G) Analysis of CL, CD, IGFBP-7, and VEGF concentration in CM from SKOV3 and A2870. Commercially available ELISAs were used for determination of VEGF, CD, and CL concentrations, whereas the IGFBP-7 ELISA protocol was developed in-house. All experiments were carried out in duplicate on three separate samples. B/D, below detection limit.
Mass Spectrometers, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/model+4800+maldi+tof+tof+analyzer/Phosphate/pmc04780753-64-16-18
Average 99 stars, based on 1 article reviews
mass spectrometers - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
4egi-1  (Bio-Techne corporation)
93
Bio-Techne corporation 4egi-1
Ovarian cancer cell secretome increases HOMEC cellular responses and contains a range of potential proangiogenic proteins. (A) Proliferation of HOMECs treated with CM from SKOV3 and A2780 cells for 24, 48, or 72 hours assessed using the WST-1 assay. Controls received basal medium only. **P ≤ .01 and ***P ≤ .001 versus control levels (100%). (B) Migration of HOMECs in co-culture with ovarian cancer cells and HDFs (co-culture control) assessed by the ThinCert migration assay. After 24 hours, fluorescence of migrated cells was quantified. ***P ≤ .001 versus control (100%) and ###P ≤ .001 versus HDFs. (C) HOMEC Oris cell migration after 48 hours in the presence of VEGFA165 (20 ng/ml) ± SU5416 (10 µM). Controls received medium alone. ***P ≤ .001 versus control (100%) and ###P ≤ .001 versus VEGFA165. (D) Migration of HOMECs in co-culture with ovarian cancer cells ± anti-VEGFA antibody (500 ng/ml) or SU5416 (10 µM) assessed by the ThinCert migration assay. ***P ≤ .001 versus control (100%), **P ≤ .01 versus control (100%), and NS versus A2780 or SKOV3. (E) VEGF- and EOC cell-induced tube-like structure formation of HOMECs and the effects of the SU5416 inhibitor. HOMECs were plated onto fibrin matrices and exposed to either VEGFA165 or EOC cells in co-culture ± SU5416 (10 µM). Negative controls received medium alone. Tube-like structure formation was quantified. *P ≤ .05, **P ≤ .01, and ***P ≤ .001 versus control (100%), ###P ≤ .001 versus VEGF, and NS versus SKOV3/A2780. For A to E, data are presented as means ± SD. P values were calculated by one-way analysis of variance (ANOVA), followed by Tukey's post hoc test. (F) Shotgun proteomics of SKOV3 CM by the <t>4800</t> <t>MALDI</t> TOF/TOF analyzer. Significant results were determined by selecting proteins that matched with two or more peptides with total ion CIs of >95%, followed by a literature search to determine proteins with a possible role in angiogenesis. (G) Analysis of CL, CD, IGFBP-7, and VEGF concentration in CM from SKOV3 and A2870. Commercially available ELISAs were used for determination of VEGF, CD, and CL concentrations, whereas the IGFBP-7 ELISA protocol was developed in-house. All experiments were carried out in duplicate on three separate samples. B/D, below detection limit.
4egi 1, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/model+4800+maldi+tof+tof+analyzer/4EGI-1/custom%404800%4030197303
Average 93 stars, based on 1 article reviews
4egi-1 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
tmb x-tra  (Kementec Solutions Inc)
94
Kementec Solutions Inc tmb x-tra
Ovarian cancer cell secretome increases HOMEC cellular responses and contains a range of potential proangiogenic proteins. (A) Proliferation of HOMECs treated with CM from SKOV3 and A2780 cells for 24, 48, or 72 hours assessed using the WST-1 assay. Controls received basal medium only. **P ≤ .01 and ***P ≤ .001 versus control levels (100%). (B) Migration of HOMECs in co-culture with ovarian cancer cells and HDFs (co-culture control) assessed by the ThinCert migration assay. After 24 hours, fluorescence of migrated cells was quantified. ***P ≤ .001 versus control (100%) and ###P ≤ .001 versus HDFs. (C) HOMEC Oris cell migration after 48 hours in the presence of VEGFA165 (20 ng/ml) ± SU5416 (10 µM). Controls received medium alone. ***P ≤ .001 versus control (100%) and ###P ≤ .001 versus VEGFA165. (D) Migration of HOMECs in co-culture with ovarian cancer cells ± anti-VEGFA antibody (500 ng/ml) or SU5416 (10 µM) assessed by the ThinCert migration assay. ***P ≤ .001 versus control (100%), **P ≤ .01 versus control (100%), and NS versus A2780 or SKOV3. (E) VEGF- and EOC cell-induced tube-like structure formation of HOMECs and the effects of the SU5416 inhibitor. HOMECs were plated onto fibrin matrices and exposed to either VEGFA165 or EOC cells in co-culture ± SU5416 (10 µM). Negative controls received medium alone. Tube-like structure formation was quantified. *P ≤ .05, **P ≤ .01, and ***P ≤ .001 versus control (100%), ###P ≤ .001 versus VEGF, and NS versus SKOV3/A2780. For A to E, data are presented as means ± SD. P values were calculated by one-way analysis of variance (ANOVA), followed by Tukey's post hoc test. (F) Shotgun proteomics of SKOV3 CM by the <t>4800</t> <t>MALDI</t> TOF/TOF analyzer. Significant results were determined by selecting proteins that matched with two or more peptides with total ion CIs of >95%, followed by a literature search to determine proteins with a possible role in angiogenesis. (G) Analysis of CL, CD, IGFBP-7, and VEGF concentration in CM from SKOV3 and A2870. Commercially available ELISAs were used for determination of VEGF, CD, and CL concentrations, whereas the IGFBP-7 ELISA protocol was developed in-house. All experiments were carried out in duplicate on three separate samples. B/D, below detection limit.
Tmb X Tra, supplied by Kementec Solutions Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/model+4800+maldi+tof+tof+analyzer/TMB+X-tra/custom%404800%4034642303
Average 94 stars, based on 1 article reviews
tmb x-tra - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
bpu 4800  (Sony)
90
Sony bpu 4800
Ovarian cancer cell secretome increases HOMEC cellular responses and contains a range of potential proangiogenic proteins. (A) Proliferation of HOMECs treated with CM from SKOV3 and A2780 cells for 24, 48, or 72 hours assessed using the WST-1 assay. Controls received basal medium only. **P ≤ .01 and ***P ≤ .001 versus control levels (100%). (B) Migration of HOMECs in co-culture with ovarian cancer cells and HDFs (co-culture control) assessed by the ThinCert migration assay. After 24 hours, fluorescence of migrated cells was quantified. ***P ≤ .001 versus control (100%) and ###P ≤ .001 versus HDFs. (C) HOMEC Oris cell migration after 48 hours in the presence of VEGFA165 (20 ng/ml) ± SU5416 (10 µM). Controls received medium alone. ***P ≤ .001 versus control (100%) and ###P ≤ .001 versus VEGFA165. (D) Migration of HOMECs in co-culture with ovarian cancer cells ± anti-VEGFA antibody (500 ng/ml) or SU5416 (10 µM) assessed by the ThinCert migration assay. ***P ≤ .001 versus control (100%), **P ≤ .01 versus control (100%), and NS versus A2780 or SKOV3. (E) VEGF- and EOC cell-induced tube-like structure formation of HOMECs and the effects of the SU5416 inhibitor. HOMECs were plated onto fibrin matrices and exposed to either VEGFA165 or EOC cells in co-culture ± SU5416 (10 µM). Negative controls received medium alone. Tube-like structure formation was quantified. *P ≤ .05, **P ≤ .01, and ***P ≤ .001 versus control (100%), ###P ≤ .001 versus VEGF, and NS versus SKOV3/A2780. For A to E, data are presented as means ± SD. P values were calculated by one-way analysis of variance (ANOVA), followed by Tukey's post hoc test. (F) Shotgun proteomics of SKOV3 CM by the <t>4800</t> <t>MALDI</t> TOF/TOF analyzer. Significant results were determined by selecting proteins that matched with two or more peptides with total ion CIs of >95%, followed by a literature search to determine proteins with a possible role in angiogenesis. (G) Analysis of CL, CD, IGFBP-7, and VEGF concentration in CM from SKOV3 and A2870. Commercially available ELISAs were used for determination of VEGF, CD, and CL concentrations, whereas the IGFBP-7 ELISA protocol was developed in-house. All experiments were carried out in duplicate on three separate samples. B/D, below detection limit.
Bpu 4800, supplied by Sony, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/model+4800+maldi+tof+tof+analyzer/bpu+4000/us11825137-106-20-19
Average 90 stars, based on 1 article reviews
bpu 4800 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
pluracol® 4815  (BASF)
90
BASF pluracol® 4815
Ovarian cancer cell secretome increases HOMEC cellular responses and contains a range of potential proangiogenic proteins. (A) Proliferation of HOMECs treated with CM from SKOV3 and A2780 cells for 24, 48, or 72 hours assessed using the WST-1 assay. Controls received basal medium only. **P ≤ .01 and ***P ≤ .001 versus control levels (100%). (B) Migration of HOMECs in co-culture with ovarian cancer cells and HDFs (co-culture control) assessed by the ThinCert migration assay. After 24 hours, fluorescence of migrated cells was quantified. ***P ≤ .001 versus control (100%) and ###P ≤ .001 versus HDFs. (C) HOMEC Oris cell migration after 48 hours in the presence of VEGFA165 (20 ng/ml) ± SU5416 (10 µM). Controls received medium alone. ***P ≤ .001 versus control (100%) and ###P ≤ .001 versus VEGFA165. (D) Migration of HOMECs in co-culture with ovarian cancer cells ± anti-VEGFA antibody (500 ng/ml) or SU5416 (10 µM) assessed by the ThinCert migration assay. ***P ≤ .001 versus control (100%), **P ≤ .01 versus control (100%), and NS versus A2780 or SKOV3. (E) VEGF- and EOC cell-induced tube-like structure formation of HOMECs and the effects of the SU5416 inhibitor. HOMECs were plated onto fibrin matrices and exposed to either VEGFA165 or EOC cells in co-culture ± SU5416 (10 µM). Negative controls received medium alone. Tube-like structure formation was quantified. *P ≤ .05, **P ≤ .01, and ***P ≤ .001 versus control (100%), ###P ≤ .001 versus VEGF, and NS versus SKOV3/A2780. For A to E, data are presented as means ± SD. P values were calculated by one-way analysis of variance (ANOVA), followed by Tukey's post hoc test. (F) Shotgun proteomics of SKOV3 CM by the <t>4800</t> <t>MALDI</t> TOF/TOF analyzer. Significant results were determined by selecting proteins that matched with two or more peptides with total ion CIs of >95%, followed by a literature search to determine proteins with a possible role in angiogenesis. (G) Analysis of CL, CD, IGFBP-7, and VEGF concentration in CM from SKOV3 and A2870. Commercially available ELISAs were used for determination of VEGF, CD, and CL concentrations, whereas the IGFBP-7 ELISA protocol was developed in-house. All experiments were carried out in duplicate on three separate samples. B/D, below detection limit.
Pluracol® 4815, supplied by BASF, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/model+4800+maldi+tof+tof+analyzer/pluracol++4815/us09670307-97-11-22
Average 90 stars, based on 1 article reviews
pluracol® 4815 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
scanning electron microscopy keyence ve-7800  (KEYENCE)
90
KEYENCE scanning electron microscopy keyence ve-7800
Ovarian cancer cell secretome increases HOMEC cellular responses and contains a range of potential proangiogenic proteins. (A) Proliferation of HOMECs treated with CM from SKOV3 and A2780 cells for 24, 48, or 72 hours assessed using the WST-1 assay. Controls received basal medium only. **P ≤ .01 and ***P ≤ .001 versus control levels (100%). (B) Migration of HOMECs in co-culture with ovarian cancer cells and HDFs (co-culture control) assessed by the ThinCert migration assay. After 24 hours, fluorescence of migrated cells was quantified. ***P ≤ .001 versus control (100%) and ###P ≤ .001 versus HDFs. (C) HOMEC Oris cell migration after 48 hours in the presence of VEGFA165 (20 ng/ml) ± SU5416 (10 µM). Controls received medium alone. ***P ≤ .001 versus control (100%) and ###P ≤ .001 versus VEGFA165. (D) Migration of HOMECs in co-culture with ovarian cancer cells ± anti-VEGFA antibody (500 ng/ml) or SU5416 (10 µM) assessed by the ThinCert migration assay. ***P ≤ .001 versus control (100%), **P ≤ .01 versus control (100%), and NS versus A2780 or SKOV3. (E) VEGF- and EOC cell-induced tube-like structure formation of HOMECs and the effects of the SU5416 inhibitor. HOMECs were plated onto fibrin matrices and exposed to either VEGFA165 or EOC cells in co-culture ± SU5416 (10 µM). Negative controls received medium alone. Tube-like structure formation was quantified. *P ≤ .05, **P ≤ .01, and ***P ≤ .001 versus control (100%), ###P ≤ .001 versus VEGF, and NS versus SKOV3/A2780. For A to E, data are presented as means ± SD. P values were calculated by one-way analysis of variance (ANOVA), followed by Tukey's post hoc test. (F) Shotgun proteomics of SKOV3 CM by the <t>4800</t> <t>MALDI</t> TOF/TOF analyzer. Significant results were determined by selecting proteins that matched with two or more peptides with total ion CIs of >95%, followed by a literature search to determine proteins with a possible role in angiogenesis. (G) Analysis of CL, CD, IGFBP-7, and VEGF concentration in CM from SKOV3 and A2870. Commercially available ELISAs were used for determination of VEGF, CD, and CL concentrations, whereas the IGFBP-7 ELISA protocol was developed in-house. All experiments were carried out in duplicate on three separate samples. B/D, below detection limit.
Scanning Electron Microscopy Keyence Ve 7800, supplied by KEYENCE, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/model+4800+maldi+tof+tof+analyzer/3d+real+surface+view+microscope+ve+9800/10__1155_slash_2017_slash_7686053-67-13-17
Average 90 stars, based on 1 article reviews
scanning electron microscopy keyence ve-7800 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Ovarian cancer cell secretome increases HOMEC cellular responses and contains a range of potential proangiogenic proteins. (A) Proliferation of HOMECs treated with CM from SKOV3 and A2780 cells for 24, 48, or 72 hours assessed using the WST-1 assay. Controls received basal medium only. **P ≤ .01 and ***P ≤ .001 versus control levels (100%). (B) Migration of HOMECs in co-culture with ovarian cancer cells and HDFs (co-culture control) assessed by the ThinCert migration assay. After 24 hours, fluorescence of migrated cells was quantified. ***P ≤ .001 versus control (100%) and ###P ≤ .001 versus HDFs. (C) HOMEC Oris cell migration after 48 hours in the presence of VEGFA165 (20 ng/ml) ± SU5416 (10 µM). Controls received medium alone. ***P ≤ .001 versus control (100%) and ###P ≤ .001 versus VEGFA165. (D) Migration of HOMECs in co-culture with ovarian cancer cells ± anti-VEGFA antibody (500 ng/ml) or SU5416 (10 µM) assessed by the ThinCert migration assay. ***P ≤ .001 versus control (100%), **P ≤ .01 versus control (100%), and NS versus A2780 or SKOV3. (E) VEGF- and EOC cell-induced tube-like structure formation of HOMECs and the effects of the SU5416 inhibitor. HOMECs were plated onto fibrin matrices and exposed to either VEGFA165 or EOC cells in co-culture ± SU5416 (10 µM). Negative controls received medium alone. Tube-like structure formation was quantified. *P ≤ .05, **P ≤ .01, and ***P ≤ .001 versus control (100%), ###P ≤ .001 versus VEGF, and NS versus SKOV3/A2780. For A to E, data are presented as means ± SD. P values were calculated by one-way analysis of variance (ANOVA), followed by Tukey's post hoc test. (F) Shotgun proteomics of SKOV3 CM by the 4800 MALDI TOF/TOF analyzer. Significant results were determined by selecting proteins that matched with two or more peptides with total ion CIs of >95%, followed by a literature search to determine proteins with a possible role in angiogenesis. (G) Analysis of CL, CD, IGFBP-7, and VEGF concentration in CM from SKOV3 and A2870. Commercially available ELISAs were used for determination of VEGF, CD, and CL concentrations, whereas the IGFBP-7 ELISA protocol was developed in-house. All experiments were carried out in duplicate on three separate samples. B/D, below detection limit.

Journal: Translational Oncology

Article Title: Epithelial Ovarian Cancer-Induced Angiogenic Phenotype of Human Omental Microvascular Endothelial Cells May Occur Independently of VEGF Signaling 1 2

doi:

Figure Lengend Snippet: Ovarian cancer cell secretome increases HOMEC cellular responses and contains a range of potential proangiogenic proteins. (A) Proliferation of HOMECs treated with CM from SKOV3 and A2780 cells for 24, 48, or 72 hours assessed using the WST-1 assay. Controls received basal medium only. **P ≤ .01 and ***P ≤ .001 versus control levels (100%). (B) Migration of HOMECs in co-culture with ovarian cancer cells and HDFs (co-culture control) assessed by the ThinCert migration assay. After 24 hours, fluorescence of migrated cells was quantified. ***P ≤ .001 versus control (100%) and ###P ≤ .001 versus HDFs. (C) HOMEC Oris cell migration after 48 hours in the presence of VEGFA165 (20 ng/ml) ± SU5416 (10 µM). Controls received medium alone. ***P ≤ .001 versus control (100%) and ###P ≤ .001 versus VEGFA165. (D) Migration of HOMECs in co-culture with ovarian cancer cells ± anti-VEGFA antibody (500 ng/ml) or SU5416 (10 µM) assessed by the ThinCert migration assay. ***P ≤ .001 versus control (100%), **P ≤ .01 versus control (100%), and NS versus A2780 or SKOV3. (E) VEGF- and EOC cell-induced tube-like structure formation of HOMECs and the effects of the SU5416 inhibitor. HOMECs were plated onto fibrin matrices and exposed to either VEGFA165 or EOC cells in co-culture ± SU5416 (10 µM). Negative controls received medium alone. Tube-like structure formation was quantified. *P ≤ .05, **P ≤ .01, and ***P ≤ .001 versus control (100%), ###P ≤ .001 versus VEGF, and NS versus SKOV3/A2780. For A to E, data are presented as means ± SD. P values were calculated by one-way analysis of variance (ANOVA), followed by Tukey's post hoc test. (F) Shotgun proteomics of SKOV3 CM by the 4800 MALDI TOF/TOF analyzer. Significant results were determined by selecting proteins that matched with two or more peptides with total ion CIs of >95%, followed by a literature search to determine proteins with a possible role in angiogenesis. (G) Analysis of CL, CD, IGFBP-7, and VEGF concentration in CM from SKOV3 and A2870. Commercially available ELISAs were used for determination of VEGF, CD, and CL concentrations, whereas the IGFBP-7 ELISA protocol was developed in-house. All experiments were carried out in duplicate on three separate samples. B/D, below detection limit.

Article Snippet: P values were calculated by one-way analysis of variance (ANOVA), followed by Tukey's post hoc test. (F) Shotgun proteomics of SKOV3 CM by the 4800 MALDI TOF/TOF analyzer.

Techniques: WST-1 Assay, Control, Migration, Co-Culture Assay, Fluorescence, Concentration Assay, Enzyme-linked Immunosorbent Assay